Clinical Trials Browser

Phase 2 × Mastocytosis, Systemic × Everolimus × Clear all

NCT00449748 2025-05-01

Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis

Phase 2 Completed

10 enrolled 4 charts

Mastocytosis, Systemic